SightfileU.S. market data from official filings

LIFEVANTAGE CORP (LFVN)

Name: LIFEVANTAGE CORP (LFVN) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000849146 · EDGAR filings · Updated 2026-07-06

LIFEVANTAGE CORP (LFVN) has reported institutional ownership of 60.1%, with 103 institutional managers holding positions valued at $32.8M per the latest 13F reporting period.

Institutional ownership

60.1%

Institutional managers

103

Reported 13F value

$32.8M

Insider activity

80 trans.

−$196.8K net selling

Latest updates

2026-07-06 — Insider transaction reported (Form 4)
2026-07-06 — Insider transaction reported (Form 4)
2026-07-06 — Insider transaction reported (Form 4)
2026-07-06 — SCHEDULE 13G/A filed
2026-06-17 — Insider transaction reported (Form 4)
2026-06-05 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, LIFEVANTAGE CORP has 103 institutional holders and institutional ownership of 60.1%.

Insider activity

Insiders reported 80 transactions (16 buys, 6 sells) across 13 reporting insiders, with a net reported value of −$196.8K.

Related companies

FRACTYL HEALTH INC (GUTS) · CHAMPIONS ONCOLOGY (CSBR) · TSCAN THERAPEUTICS INC (TCRX) · CELLECTIS S A (CLLS) · CONNECT BIOPHARMA HLDGS LTD (CNTB) · COYA THERAPEUTICS INC (COYA)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-06.